CN1626217A - 仙人掌粉刺膏 - Google Patents
仙人掌粉刺膏 Download PDFInfo
- Publication number
- CN1626217A CN1626217A CN 200410043793 CN200410043793A CN1626217A CN 1626217 A CN1626217 A CN 1626217A CN 200410043793 CN200410043793 CN 200410043793 CN 200410043793 A CN200410043793 A CN 200410043793A CN 1626217 A CN1626217 A CN 1626217A
- Authority
- CN
- China
- Prior art keywords
- extract
- radix
- cactus
- squalane
- butanediol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 17
- 206010000496 acne Diseases 0.000 title claims abstract description 17
- 241000219357 Cactaceae Species 0.000 title abstract 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 27
- 239000000284 extract Substances 0.000 claims abstract description 27
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 16
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000006071 cream Substances 0.000 claims abstract description 14
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 13
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000004359 castor oil Substances 0.000 claims abstract description 9
- 235000019438 castor oil Nutrition 0.000 claims abstract description 9
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims abstract description 9
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 9
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940051841 polyoxyethylene ether Drugs 0.000 claims abstract description 9
- 229920000056 polyoxyethylene ether Polymers 0.000 claims abstract description 9
- 235000019830 sodium polyphosphate Nutrition 0.000 claims abstract description 9
- 229940032094 squalane Drugs 0.000 claims abstract description 9
- -1 nipagin methyl ester Chemical class 0.000 claims abstract description 8
- 229960005150 glycerol Drugs 0.000 claims abstract description 4
- 239000002253 acid Substances 0.000 claims description 14
- 229920001577 copolymer Polymers 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 7
- 229940084106 spermaceti Drugs 0.000 claims description 7
- 239000012177 spermaceti Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 229930013930 alkaloid Natural products 0.000 abstract description 4
- 150000003797 alkaloid derivatives Chemical class 0.000 abstract description 4
- 229930003944 flavone Natural products 0.000 abstract description 4
- 235000011949 flavones Nutrition 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 abstract 3
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 abstract 3
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 abstract 3
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 abstract 3
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 abstract 2
- OEOIWYCWCDBOPA-UHFFFAOYSA-N 6-methyl-heptanoic acid Chemical compound CC(C)CCCCC(O)=O OEOIWYCWCDBOPA-UHFFFAOYSA-N 0.000 abstract 2
- 229940074979 cetyl palmitate Drugs 0.000 abstract 2
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 abstract 2
- 229920000058 polyacrylate Polymers 0.000 abstract 2
- 241000628997 Flos Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241001106477 Paeoniaceae Species 0.000 abstract 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 abstract 1
- 150000002212 flavone derivatives Chemical class 0.000 abstract 1
- 239000010977 jade Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 abstract 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 abstract 1
- 229960002216 methylparaben Drugs 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 150000002213 flavones Chemical class 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 241000223229 Trichophyton rubrum Species 0.000 description 2
- 241001480046 Trichophyton schoenleinii Species 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
仙人掌粉刺膏，由仙人掌萃取物、白芍萃取物、甘草苷加氢蓖麻油聚氧乙烯醚、甘油、角鲨烷、尼泊金甲酯、丙烯酸聚合物、二丙二醇醚、1.3一丁二醇、异辛酸鲸蜡酸酯、多聚磷酸钠、氢氧化钠制成，其特点100g成品各组份的配比：仙人掌萃取物4－7g、白芍萃取物1.5－2.5g、甘草苷1.5－2.5g、加氢蓖麻油聚氧乙烯醚3.8－4.4ml、甘油16－22ml、角鲨烷11－13g、尼泊金甲酯2－2.2ml、丙烯酸聚合物0.4－0.7g、二丙二醇醚16－22ml、1.3一丁二醇8－12ml、异辛酸鲸蜡酸酯18－22g、多聚磷酸钠0.15－0.17g、氢氧化钠0.2－0.3g配制成。本品中的仙人掌萃取物含有总黄酮、生物碱、抱壁莲、玉芙蓉等生理活性成分，配以白芍萃取物及甘草苷，对病菌有抑制作用，具有清热解毒、活血消肿的功能。
Description
技术领域：
本发明是涉及一种用于粉刺的保健护理用膏剂。
技术背景：
粉刺多发而且常见，严重影响人的美容及身心健康，目前虽有较多处理粉刺的产品，但其疗效不理想。特别是青年人，需要一种快速消除粉刺，而且具有调节内分泌，清热凉血，活血消肿功能的膏剂，满足美容的需要。
发明内容：
本发明的目的是提出一种仙人掌粉刺膏，由于仙人掌含有生物碱、总黄酮、三萜皂甙，具有保健、护理，无毒副作用的膏剂，为人类健康服务。
本发明仙人掌粉刺膏，以仙人掌为主要成分，配伍白芍萃取物、甘草苷，加入辅料加氢蓖麻油聚氧乙烯醚、甘油、角鲨烷、尼泊金甲酯、丙烯酸聚合物、二丙二醇醚、1.3一丁二醇、异辛酸鲸蜡酸酯、多聚磷酸钠、氢氧化钠组成，其特征在于：配制100g成品时各组份的配比：仙人掌萃取物4-7g、白芍萃取物1.5-2.5g、甘草苷1.5-2.5g、加氢蓖麻油聚氧乙烯醚3.8-4.4ml、甘油16-22ml、角鲨烷11-13g、尼泊金甲酯2-2.2ml、丙烯酸聚合物0.4-0.7g、二丙二醇醚16-22ml、1.3一丁二醇8-12ml、异辛酸鲸蜡酸酯18-22g、多聚磷酸钠0.15-0.17g、氢氧化钠0.2-0.3g，配制成仙人掌粉刺膏。
仙人掌粉刺膏各主要原料的作用：
1、仙人掌萃取物含有总黄酮、生物碱、抱壁莲、玉芙蓉等生理活化成分，配以白芍萃取物、甘草苷、对多种病菌和许兰氏毛菌、红色表皮癣菌等都有很强的抑制作用。
2、白芍萃取物：抑菌消炎、抗溃疡。
3、甘草苷：抗炎剂、抑菌。
4、鱼鲨烷：皮肤润滑剂。
5、尼泊金甲酯：防腐剂。
本发明与现有的技术相比，仙人掌粉刺膏采用仙人掌萃取物为主要成分，加入白芍萃取物及甘草苷等原料配制而成。由于仙人掌萃取物中含有生物碱，总黄酮、抱壁莲、玉芙蓉等生理活性成分，配伍白芍萃取物、甘草苷等有效成分，对多种致病菌如许兰氏毛菌、红色表皮癣菌、腹股沟表面癣菌等都有很强的抑制作用。仙人掌粉刺膏具有调节内分泌、清热凉血、活血消肿的作用，对皮肤无毒副作用，满足人们的需求。
具体实施方式：
仙人掌粉刺膏，由仙人掌萃取物、白芍萃取物、甘草苷、加氢蓖麻油聚氧乙烯醚、甘油、角鲨烷、尼泊金甲酯、丙烯酸聚合物、二丙二醇醚、1.3一丁二醇、异辛酸鲸蜡酸酯、多聚磷酸钠、氢氧化钠配制而成，其每100g中各种组份的配比：仙人掌萃取物4-7g、白芍萃取物1.5-2.5g、甘草苷1.5-2.5g、加氢蓖麻油聚氧乙烯醚3.8-4.4ml、甘油16-22ml、角鲨烷11-13g、尼泊金甲酯2-2.2ml、丙烯酸聚合物0.4-0.7g、二丙二醇醚16-22ml、1.3一丁二醇8-12ml、异辛酸鲸蜡酸酯18-22g、多聚磷酸钠0.15-0.17g、氢氧化钠0.2-0.3g。
首先将仙人掌干燥后压粗粉，加7倍量80％酒精热回流提取6小时，残渣按上清重提取，合并2次滤液，减压回收酒精，滤液加1/3量石油醚，充分萃取，静置10小时，取水层，减压浓缩至一定体积，得仙人掌萃取物。白芍根皮压粗粉，用3倍量的石油醚热回流提取后，取出滤渣加入30％酒精溶液(1∶20，质量比)，分二次低温(15-30℃)浸提24小时，合并提取液，滤清后加入少量明胶(以溶解为限)，冷冻过夜过滤，滤液减压浓缩至一定体积，即为芍药提取液。甘草压粗粉，以水、己烷、丙酮混合溶剂(10∶1∶4)热回流提取，提取液滤清后回收有机溶媒，水相以正丁醇萃取数次，合并正于醇溶液，减压浓缩即得甘草苷。
实施例：
按上述配比：配制100g成品，取了仙人掌萃取物6g、白芍萃取物2.1g、甘草苷2g、加氢蓖麻油聚氧乙烯醚4ml、甘油20ml、角鲨烷12g、尼泊金甲酯2.2ml、丙烯酸聚合物0.6g、二丙二醇醚20ml、1.3一丁二醇10ml、异辛酸鲸蜡酸酯20.7g、多聚磷酸钠0.16g、氢氧化钠0.24g。
按水相、油相分别放入2只150ml烧杯中。油加热至95℃，水沸腾。将油相放置于搅拌下，开始搅拌，以不溅出烧杯为度。慢慢地将另一烧杯中的水倾入，直至加完。再继续搅拌一分钟后，记录乳化温度，然后边搅拌边冷却，进行结膏，香精在结膏之前50℃时加入，再缓缓搅拌，35-36℃停止搅拌，冷却后即可仙人掌粉刺膏。
Claims (1)
1、仙人掌粉刺膏，由白芍萃取物、甘草苷、加氢蓖麻油聚氧乙烯醚、甘油、角鲨烷、尼泊金甲酯、丙烯酸聚合物、二丙二醇醚、1.3一丁二醇、异辛酸鲸蜡酸酯、多聚磷酸钠、氢氧化钠组成，其特征在于：配制100g成品时各组份的配比：仙人掌萃取物4-7g、白芍萃取物1.5-2.5g、甘草苷1.5-2.5g、加氢蓖麻油聚氧乙烯醚3.8-4.4ml、甘油16-22ml、角鲨烷11-13g、尼泊金甲酯2-2.2ml、丙烯酸聚合物0.4-0.7g、二丙二醇醚16-22ml、1.3一丁二醇8-12ml、异辛酸鲸蜡酸酯18-22g、多聚磷酸钠0.15-0.17g、氢氧化钠0.2-0.3g，配制成仙人掌粉刺膏。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410043793 CN1626217A (zh) | 2004-08-12 | 2004-08-12 | 仙人掌粉刺膏 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410043793 CN1626217A (zh) | 2004-08-12 | 2004-08-12 | 仙人掌粉刺膏 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1626217A true CN1626217A (zh) | 2005-06-15 |
Family
ID=34763770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410043793 Pending CN1626217A (zh) | 2004-08-12 | 2004-08-12 | 仙人掌粉刺膏 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1626217A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106473944A (zh) * | 2016-12-15 | 2017-03-08 | 广东科玮生物技术股份有限公司 | 一种含抗菌肽的祛痘组合物及祛痘霜 |
-
2004
- 2004-08-12 CN CN 200410043793 patent/CN1626217A/zh active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106473944A (zh) * | 2016-12-15 | 2017-03-08 | 广东科玮生物技术股份有限公司 | 一种含抗菌肽的祛痘组合物及祛痘霜 |
| CN106473944B (zh) * | 2016-12-15 | 2019-07-02 | 广东科玮生物技术股份有限公司 | 一种含抗菌肽的祛痘组合物及祛痘霜 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105616283B (zh) | 一种植物精粹修护面霜 | |
| CN103356442B (zh) | 一种以植物提取物为主要功能成分的防晒霜的生产方法 | |
| CN101229109B (zh) | 一种适于7-12个月婴儿皮肤特点的护肤品及其制备工艺 | |
| Celestino et al. | Acute toxicity and laxative activity of Aloe ferox resin | |
| CN109330935B (zh) | 具有抗炎抗敏功效的化妆品用紫草组合物及其应用 | |
| CN105779175A (zh) | 一种具有祛痘功能的天然手工皂及其制备方法 | |
| CN107411987B (zh) | 一种面部清痘复方精油及其制备方法 | |
| CN1915351A (zh) | 一种用于烧、烫伤治疗及祛痘产品的中药组合物及其制备方法 | |
| JP4869482B2 (ja) | 美白化粧料 | |
| CN109700723A (zh) | 一种抗菌止血牙膏组合物及其制备方法 | |
| CN108158938A (zh) | 一种含美洲大蠊成分的祛痘面霜及其制备方法 | |
| CN108158912B (zh) | 一种水飞蓟祛痘修痕凝胶及其制备方法 | |
| CN105267261A (zh) | 一组具有促进皮肤修复及愈合功能的植物提取物组合 | |
| CN111000762A (zh) | 一种本草紧肤精油及其制备方法 | |
| JP2009132651A (ja) | 紫外線防御剤 | |
| CN110368331A (zh) | 一种含岗松精油的消炎祛痘修复面膜液及其制备方法 | |
| CN1626217A (zh) | 仙人掌粉刺膏 | |
| KR20090075950A (ko) | 난치성 아토피성 피부염 치료용 조성물 | |
| CN110812377B (zh) | 一种痤疮治疗修复组合物及其应用 | |
| CN110090193B (zh) | 一种具有减脂功效的祛痘保湿精华液及其制备方法 | |
| KR101211754B1 (ko) | 천연 추출물을 함유하는 스트레스성 여드름 개선용 화장료 조성물 | |
| CN111773149A (zh) | 一种护肤组合物及其制备方法 | |
| CN111686056A (zh) | 一种含天然龙血竭提取物的润唇膏制作方法 | |
| CN108685788A (zh) | 一种球兰抗氧化护肤霜及其制备方法 | |
| CN1120952A (zh) | 一种具有治疗疤痕、痤疮功效的化妆品及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |